ArticleOncoTargets and therapy2019

Sphingosine kinase 2 inhibitor ABC294640 displays anti-epithelial ovarian cancer activities in vitro and in vivo.

Keqi Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.